A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Hackensack Meridian Health
Gilead Sciences
Medical College of Wisconsin
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
Medical College of Wisconsin
UNC Lineberger Comprehensive Cancer Center
Gilead Sciences
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
H. Lee Moffitt Cancer Center and Research Institute
Case Comprehensive Cancer Center
French Innovative Leukemia Organisation
Gilead Sciences
Center for International Blood and Marrow Transplant Research
Masonic Cancer Center, University of Minnesota
Janssen Scientific Affairs, LLC
Thomas Jefferson University
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Gilead Sciences
Stanford University
St. Petersburg State Pavlov Medical University
M.D. Anderson Cancer Center
University of Alabama at Birmingham
IRCCS San Raffaele
M.D. Anderson Cancer Center
Northside Hospital, Inc.
Masonic Cancer Center, University of Minnesota
West Virginia University
GWT-TUD GmbH
Northside Hospital, Inc.
GlaxoSmithKline
National Institutes of Health Clinical Center (CC)
National Heart, Lung, and Blood Institute (NHLBI)
Memorial Sloan Kettering Cancer Center
Medical College of Wisconsin
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
University of Liege
German CLL Study Group
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
University College, London